Market Overview:
The global seizure treatments market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the seizure treatments market can be attributed to factors such as increasing prevalence of seizures, rising awareness about available treatment options, and technological advancements in the field of seizure treatments. The global seizure treatments market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into anticonvulsant therapy and surgery. Anticonvulsant therapy dominates the global seizure treatments market owing to its high efficacy and safety profile as compared to surgery. On the basis of application, hospitals account for a major share of the global seizures treatment market due to increasing number of patients with epilepsy seeking hospital-based care for their condition.
Product Definition:
There are many types of seizure treatments. The most common type of treatment is medication. Other treatments include surgery, diet, and lifestyle changes.
Anticonvulsant Therapy:
Anticonvulsants are a class of drug used to prevent or reduce seizures. They can be used in combination with other drugs to help control the seizures. Some anticonvulsants are also used for treating status epilepticus, which is an acute prolonged seizure that occurs as a result of epilepsy.
Surgery:
Surgery is a medical procedure used to cure, diagnose, or alter a health problem. It involves the use of surgical tools and machines that help doctors and surgeons perform operations. The main goal of surgery is to restore the body's natural functions by repairing damaged cells or tissues. Surgery can be performed on any part of the human body but it usually involves operating on internal organs such as lungs, liver, heart, brain etc.
Application Insights:
Based on the application, the global seizure treatments market is segmented into hospitals, clinics and ambulatory surgical centers. The hospitals segment dominated the market in 2017 owing to factors such as a high prevalence of epilepsy and increasing awareness among patients regarding treatment options. According to WHO, approximately 50 million people are living with epilepsy worldwide. Epilepsy is considered a chronic disease as it affects an individual for life span of 7 years or more and requires lifelong management. Thus, increasing incidence rates of epilepsy coupled with rising awareness about available treatment options are expected to drive growth in this segment over the forecast period.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of key players, availability of novel drugs and increasing incidence rate of epilepsy. The region is expected to maintain its dominance during the forecast period due to factors such as favorable government initiatives, high healthcare expenditure and awareness campaigns regarding available treatment options.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising disposable income levels in emerging economies such as India & China, improving healthcare infrastructure and growing patient awareness about antiseizure medication. Furthermore, an increase in cases diagnosed with epilepsy coupled with rise in demand for cost-effective treatment options will drive regional market growth during the estimated time span.
Growth Factors:
- Increasing incidence of seizure disorders: The global prevalence of seizure disorders is estimated to be around 50 million, and it is expected to increase due to the increasing aging population. This will create a larger patient pool for seizure treatments market.
- Growing demand for novel therapies: There is a growing demand for novel therapies with better efficacy and fewer side effects. This will drive the growth of the seizure treatments market.
- Technological advancements in treatment options: There has been significant technological advancement in the field of seizures treatment over the past few years, which has led to introduction of new and more effective therapies into the market. This will fuel the growth of this market in coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Seizure Treatments Market Research Report
By Type
Anticonvulsant Therapy, Surgery
By Application
Hospitals, Clinics, Ambulatory Surgical Centers
By Companies
Abbott Laboratories, Cephalon, Novartis, Pfizer, Johnson and Johnson, GlaxoSmithKline, Sanofi, Sunovion Pharmaceuticals, Bausch Health
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
145
Number of Tables & Figures
102
Customization Available
Yes, the report can be customized as per your need.
Global Seizure Treatments Market Report Segments:
The global Seizure Treatments market is segmented on the basis of:
Types
Anticonvulsant Therapy, Surgery
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Ambulatory Surgical Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Cephalon
- Novartis
- Pfizer
- Johnson and Johnson
- GlaxoSmithKline
- Sanofi
- Sunovion Pharmaceuticals
- Bausch Health
Highlights of The Seizure Treatments Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Anticonvulsant Therapy
- Surgery
- By Application:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Seizure Treatments Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Seizure treatments are medications or procedures that help to control seizures. Some seizure treatments work by stopping the seizure before it starts, while others work by controlling the symptoms of a seizure.
Some of the major players in the seizure treatments market are Abbott Laboratories, Cephalon, Novartis, Pfizer, Johnson and Johnson, GlaxoSmithKline, Sanofi, Sunovion Pharmaceuticals, Bausch Health.
The seizure treatments market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Seizure Treatments Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Seizure Treatments Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Seizure Treatments Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Seizure Treatments Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Seizure Treatments Market Size & Forecast, 2020-2028
4.5.1 Seizure Treatments Market Size and Y-o-Y Growth
4.5.2 Seizure Treatments Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Anticonvulsant Therapy
5.2.2 Surgery
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Ambulatory Surgical Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Seizure Treatments Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Seizure Treatments Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Anticonvulsant Therapy
9.6.2 Surgery
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Ambulatory Surgical Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Anticonvulsant Therapy
10.6.2 Surgery
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Ambulatory Surgical Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Anticonvulsant Therapy
11.6.2 Surgery
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Ambulatory Surgical Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Anticonvulsant Therapy
12.6.2 Surgery
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Ambulatory Surgical Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Anticonvulsant Therapy
13.6.2 Surgery
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Ambulatory Surgical Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Seizure Treatments Market: Competitive Dashboard
14.2 Global Seizure Treatments Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Cephalon
14.3.3 Novartis
14.3.4 Pfizer
14.3.5 Johnson and Johnson
14.3.6 GlaxoSmithKline
14.3.7 Sanofi
14.3.8 Sunovion Pharmaceuticals
14.3.9 Bausch Health
